Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer

Use of a combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer

US Patent 11918580 · Granted Mar 5, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for the treatment of tumors2025
Compounds and compositions for the treatment of tumors2025
Systems and methods for training machine learning algorithms for inverse problem2024
Spirocyclic derivatives as histone deacetylase inhibitors2015
Spirocyclic derivatives as histone deacetylase inhibitors2015
Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LS2014
Acrylomido derivatives useful as inhibitors of the mitochondrial permeability tr2014
Spirocyclic derivatives as histone deacetylase inhibitors2013
Acrylamido derivatives useful as inhibitors of the mitochondrial permeability tr2013
Class of histone deacetylase inhibitors2012
Class of histone deacetylase inhibitors2012
Histone deacetylases inhibitors2011